Spots Global Cancer Trial Database for adenosine a2a receptor antagonist
Every month we try and update this database with for adenosine a2a receptor antagonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers | NCT02111330 | Parkinson Disea... | PBF-509 Placebo | 18 Years - 45 Years | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | NCT02403193 | Non-small Cell ... | PBF-509_80 mg PBF-509_160 mg PBF-509_320 mg PBF-509_640 mg Combo PBF-509 (... Combo PBF-509 (... Combo PBF-509 (... RP2D (PBF-509+P... Experimental: R... | 18 Years - | Palobiofarma SL |